Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Clinical trial NCT01039363 · UNKNOWN
Trial details
- NCT number
- NCT01039363
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.